CASE Opposes Calls for Foreign Price Controls in Medicaid
(Alexandria, Virginia) — Today, Gerard Scimeca, Chairman of Consumer Action for a Strong Economy (CASE), issued the following statement in...
CASE Letter to Michigan House Insurance and Financial Services Committee Opposing HB 5350
December 2, 2024 Re: Michigan HB. 5350 Minority Vice Chair Harris, and Members of the House Insurance and Financial Services...
Hospital Consolidation Driving Up Prices For Consumers
On November 6, voters consistently identified healthcare as the number one issue they were concerned about. Put a different way:...
Hospitals Complain They Need More Free Government Money
This week, multiple associations and hospital groups refiled a lawsuit to reverse changes made to the 340B program. We’ve written...
Sec. Azar: Hospitals Pocket Billions from 340B Program at Expense of Consumers & Taxpayers, Program In Need of Reform
Last week, U.S. Health and Human Services (HHS) Secretary Alex Azar testified before Congress on the 340B program, an almost...
CASE Op-Ed – Washington Examiner: A Wishlist for Our Healthcare System Ahead of the Midterms
Matthew Kandrach – President, CASE July 12, 2018 – https://washex.am/2ufXYBS With summer upon us and the midterm elections looming large, Congress...
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/